Reply to Comment on: Treatment of EBV-Associated Nodular Sclerosing Hodgkin Lymphoma in a Patient With Ataxia Telangiectasia With Brentuximab Vedotin and Reduced COPP Plus Rituximab

Michael T Meister, Sandra Voss, Dirk Schwabe

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)947
Number of pages1
JournalPediatric blood & cancer
Issue number5
Publication statusPublished - May 2016
Externally publishedYes


  • Antineoplastic Combined Chemotherapy Protocols/administration & dosage
  • Ataxia Telangiectasia/drug therapy
  • Epstein-Barr Virus Infections/drug therapy
  • Herpesvirus 4, Human
  • Hodgkin Disease/drug therapy
  • Humans
  • Immunoconjugates/administration & dosage
  • Male
  • Rituximab/administration & dosage

Cite this